Skip to content
RESEARCH USE ONLYFor research purposes onlyMÉXICO
Peptides MEX

Peptides MEX / Comparisons

Epithalon vs FOXO4-DRI: telomeres and cellular senescence

Epithalon and FOXO4-DRI appear in discussions of aging, but address different experimental questions. Epithalon was studied for telomere and cell-division changes; FOXO4-DRI was designed to disrupt an interaction supporting survival of certain senescent cells.

Updated · Sources and editorial standards

Key differences: Epithalon / FOXO4-DRI
FeatureEpithalonFOXO4-DRI
Central question[1][2]Telomerase and proliferative capacitySenescent-cell survival
Investigated process[1][2]Telomere elongation in cultureFOXO4-p53 interference and apoptosis
Source models[3][2]Cultured human fibroblastsCell cultures and mice

Preserving division and removing cells are different objectives

Epithalon experiments reported telomerase activity and telomere elongation in cultured human fibroblasts. FOXO4-DRI sought to interfere with FOXO4-p53 binding and trigger apoptosis in senescent cells. Lengthening a chromosomal marker and reducing survival of a cell population are not opposite ends of one measurement scale.

Sources: [1][2]

The Epithalon experiment was cell-based

The 2004 study followed the proliferative capacity of fetal lung fibroblasts over successive passages. The authors observed additional divisions in treated cells. A culture passage records laboratory cell growth; it does not represent a year of human life or an organ-function measurement.

Sources: [3]

FOXO4-DRI moved from cultures to mouse models

The 2017 study combined cell experiments with mouse models of chemotherapy-related damage and aging. It examined cell survival and functional variables including renal function. The D-retro-inverso modification was part of the peptide design. These preclinical results do not constitute a human-longevity comparison with Epithalon.

Sources: [2]

Questions about this reference

Is Epithalon a senolytic like FOXO4-DRI?

The cited Epithalon work focused on telomerase, telomeres and proliferation. FOXO4-DRI research investigated senescent-cell removal through apoptosis. These studies do not justify assigning them the same mechanism.

[1][2]

Does a cell dividing more demonstrate longer lifespan?

It demonstrates a proliferation result in that culture. Establishing human lifespan or health outcomes requires measuring those outcomes in people; cell passages do not substitute for them.

[3]

Sources and original reading

  1. Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells
  2. Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging
  3. Peptide promotes overcoming of the division limit in human somatic cell

Content updated: . How this content is prepared and checked.